Clinical efficacy of estradiolvalerate combined progesterone in treatment of perimenopausal syndrome

Ning Xinxi
Abstract:Objective To investigate the clinical efficacy of estradiolvalerate joint progesterone in treatment of perimenopausal syndrome. Methods A total of 170 patients with perimenopausal syndrome in this study, all of them both were selected from March 2014 to March 2015 in our hospital, the patients were divided into two groups, the control group and the observation group, each of 85 cases, The control group received conventional treatment, observation group were given progesterone capsules combined with estradiol valerate tablets. The clinical efficacy and hormone levels before and after treatment of two groups were compared. Results The total efficacy rate of the observation group was significantly higher than the control group( P0.05). After treatment, FSH, LH levels of two groups were lower than before treatment, while E2 levels were higher than before treatment(P0.05); The FSH, LH levels of observation group after treatment were lower than the control group after treatment, while E2 level was higher than the control group after treatment(P0.05). Conclusion The efficacy of estradiolvalerate joint capsule progesterone in treatment of perimenopausal syndrome is exact, can significantly improve the clinical efficacy of hormone levels, make effective improvements, and can be popularized in clinical application.
Medicine
What problem does this paper attempt to address?